An antibody against DR4 (TRAIL-R1) in combination with doxorubicin selectively kills malignant but not normal prostate cells (Q53922832): Preview

An antibody against DR4 (TRAIL-R1) in combination with doxorubicin selectively kills malignant but not normal prostate cells (Q53922832)
scientific article

Language:

Current Data About An antibody against DR4 (TRAIL-R1) in combination with doxorubicin selectively kills malignant but not normal prostate cells

(P31)

(Q13442814)

(P248)
(P698)	12878867
(P813)	Tuesday, May 22, 2018
(P854)	http://europepmc.org/abstract/MED/12878867

(P304)

283-290

(P248)
(P698)	12878867
(P813)	Tuesday, May 22, 2018
(P854)	http://europepmc.org/abstract/MED/12878867

(P433)

(P248)
(P698)	12878867
(P813)	Tuesday, May 22, 2018
(P854)	http://europepmc.org/abstract/MED/12878867

(P478)

(P248)
(P698)	12878867
(P813)	Tuesday, May 22, 2018
(P854)	http://europepmc.org/abstract/MED/12878867

(P577)

Thursday, May 1, 2003

(P248)
(P698)	12878867
(P813)	Tuesday, May 22, 2018
(P854)	http://europepmc.org/abstract/MED/12878867

(P921)

(Q79460)

(P887)

(Q18936)

(P887)

(P1433)

(Q2544651)

(P248)
(P698)	12878867
(P813)	Tuesday, May 22, 2018
(P854)	http://europepmc.org/abstract/MED/12878867

(P1476)

"An antibody against DR4 (TRAIL-R1) in combination with doxorubicin selectively kills malignant but not normal prostate cells" (language: en)

(P248)
(P698)	12878867
(P813)	Tuesday, May 22, 2018
(P854)	http://europepmc.org/abstract/MED/12878867

(P2093)

Christina Voelkel-Johnson

(P1545)	1

(P248)
(P698)	12878867
(P813)	Tuesday, May 22, 2018
(P854)	http://europepmc.org/abstract/MED/12878867

other details

description	scientific article

External Links

(P356)	10.4161/CBT.2.3.398
(P698)	12878867
(P5875)	10646295